IBS-smart

Overview

IBS-smart provides an evaluation of plasma anti-CdtB and anti-vinculin antibody levels, focusing on patterns observed in relation to post-infectious digestive conditions. The test offers results indicating whether these biomarkers are elevated compared to normal reference ranges, which can support an understanding of biochemical variations at the time of sample collection. These markers have been the subject of research aimed at exploring links with gastrointestinal symptoms and changes in digestive function.

This analysis may be of interest for those investigating persistent digestive irregularities such as changes in bowel habits, abdominal discomfort, bloating, or symptom patterns that may follow gastrointestinal disturbances. Anti-CdtB and anti-vinculin antibodies have been researched in various digestive contexts, with studies noting patterns that may reflect immune responses. Considering both markers together may provide additional insight into underlying factors connected to digestive health and symptom expression.

Practitioners often use IBS-smart alongside a comprehensive review of symptom history, stool analysis, dietary habits and other functional assessments to gain a more rounded understanding of digestive function. When interpreted as part of a holistic approach, the test can contribute to a broader picture of digestive wellness and support lifestyle or nutritional considerations for individuals experiencing variable bowel patterns.

IBS-smart is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. IBS-smart is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.